GHU Logo
The Great Heights University Library
Academic discovery, digital access, and research support

Clinical Drug Investigation (Record no. 4210)

MARC details
000 -LEADER
fixed length control field 01879nas a22003255i 4500
001 - CONTROL NUMBER
control field 1179-1918
003 - CONTROL NUMBER IDENTIFIER
control field DE-He213
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20260610082530.0
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr nn 008mamaa
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 150723s||||||||sz uu poo|||||| b|EN |d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1179-1918
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1007/40261.1179-1918
Source of number or code doi
210 10 - ABBREVIATED TITLE
Abbreviated title Clin Drug Investig
245 10 - TITLE STATEMENT
Title Clinical Drug Investigation
Medium [electronic resource] /
Statement of responsibility, etc. edited by Sophie Stevenson, Jasbir Singh.
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture Cham :
Name of producer, publisher, distributor, manufacturer Springer International Publishing :
-- Imprint: Adis.
300 ## - online resource
Other physical details online resource.
520 ## - SUMMARY, ETC.
Summary, etc. Clinical Drug Investigation provides rapid publication of original research covering all phases of clinical drug development and therapeutic use of drugs. The Journal includes: Clinical trials, outcomes research, clinical pharmacoeconomic studies and pharmacoepidemiology studies with a strong link to optimum prescribing practice for a drug or group of drugs. Clinical pharmacodynamic and clinical pharmacokinetic studies with a strong link to clinical practice. Pharmacodynamic and pharmacokinetic studies in healthy volunteers in which significant implications for clinical prescribing are discussed. Studies focusing on the application of drug delivery technology in healthcare. Short communications and case study reports that meet the above criteria will also be considered.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Therapeutics.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pharmacology.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Internal medicine.
650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Therapeutics.
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pharmacology.
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Internal Medicine.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Stevenson, Sophie.
Relator term editor.
Relationship edt
-- http://id.loc.gov/vocabulary/relators/edt
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Singh, Jasbir.
Relator term editor.
Relationship edt
-- http://id.loc.gov/vocabulary/relators/edt
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element SpringerLink (Online service)
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Printed version:
International Standard Serial Number 1173-2563
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1007/40261.1179-1918">https://doi.org/10.1007/40261.1179-1918</a>
Public note Hybrid

No items available.